Key facts
- Deep Track Capital is a venture capital firm based in Greenwich, Connecticut with 16 tracked portfolio companies.
- Notable positions include Tubulis, Halda Therapeutics, 35Pharma, Avenzo Therapeutics, Latigo Bio.
- Deep Track Capital has 4 funds on record, raising $2.6B across the 2 that report a size.
- The team roster lists 15 people.
- Deep Track Capital reports $5.6B in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About Deep Track Capital
Founded in 2020, Deep Track Capital is a venture capital investment firm based in Greenwich, Connecticut. The firm seeks to invest in companies operating in the biotechnology and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
Registered with the SEC
Form ADV · 2026-03 · CRD 312459- Regulatory AUM
- $5.6B
- Private fund assets
- $8.4B
- Private funds
- 2 · 2 hedge
- Staff
- 19
- Registered office
- GREENWICH, CT
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as DEEP TRACK CAPITAL, LP).
Free account
See the whole book
- ·The book's top 25 — of 16 recorded positions
- ·Watchlist + alerts for Deep Track Capital's activity
Create free account
No card required
Portfolio, priced
16 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Tubulis | Drug Discovery | $5.8B | — | |
| Halda Therapeutics | Drug Discovery | $3.0B | — | |
| 35Pharma | — | $950.0M | — | |
| Avenzo Therapeutics | — | $590.0M | — | |
| Latigo Bio | — | $530.0M | — | |
| Diagonal Therapeutics | Drug Discovery | $458.5M | — | |
| Hemab Therapeutics Holdings | Drug Discovery | $386.9M | — | |
| Attovia Therapeutics | — | $370.0M | — | |
| Triveni Bio | Drug Discovery | $310.0M | — | |
| Artios | Drug Discovery | $260.3M | — | |
| Arbor Biotechnologies | — | $238.9M | — | |
| Ambrosia Biosciences | — | $203.0M | — | |
| Imbria Pharmaceuticals | Drug Discovery | $131.7M | — | |
| TORL BioTherapeutics | Drug Discovery | — | — | |
| SeraGene Therapeutics | — | — | — | |
| + 1 more companies · a free account shows the top of the book | ||||
Funds
4 recorded- Deep Track Special Opportunities Fund, LP2025—
- Deep Track Special Opportunities Offshore Fund, LP2025—
- Deep Track Biotechnology Fund, LP2021$842.0M
- Deep Track Biotechnology Offshore Fund, Ltd.2021$1.7B
$2.6B raised across the 2 funds that report a size
Team
15 people on record — 15 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Deep Track Capital invest in?
- Deep Track Capital has 16 recorded portfolio companies, including Tubulis, Halda Therapeutics, 35Pharma, Avenzo Therapeutics.
- What is Deep Track Capital's AUM?
- Deep Track Capital manages approximately $5.2B in assets.